GENOMIC HEALTH INC (GHDX) Stock Price, Quote, News and Overview
NASDAQ:GHDX - Nasdaq -
GHDX Quote, Performance and Key Statistics
63.44
-0.44 (-0.69%)
The current stock price of GHDX is 63.44 null. In the past month the price decreased by -6.57%. In the past year, price decreased by -22.32%.
About GHDX
Company Profile
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.
Company Info
GENOMIC HEALTH INC
301 PENOBSCOT DRIVE
REDWOOD CITY CA 94063
CEO: Kimberly J. Popovits
Phone: 650-556-9300
GENOMIC HEALTH INC / GHDX FAQ
What is the stock price of GENOMIC HEALTH INC today?
The current stock price of GHDX is 63.44 null. The price decreased by -0.69% in the last trading session.
What is the ticker symbol for GENOMIC HEALTH INC stock?
The exchange symbol of GENOMIC HEALTH INC is GHDX and it is listed on the Nasdaq exchange.
On which exchange is GHDX stock listed?
GHDX stock is listed on the Nasdaq exchange.
What is GENOMIC HEALTH INC worth?
GENOMIC HEALTH INC (GHDX) has a market capitalization of 2.38B null. This makes GHDX a Mid Cap stock.
What are the support and resistance levels for GENOMIC HEALTH INC (GHDX) stock?
GENOMIC HEALTH INC (GHDX) has a support level at 63.43 and a resistance level at 67.85. Check the full technical report for a detailed analysis of GHDX support and resistance levels.
Should I buy GENOMIC HEALTH INC (GHDX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GHDX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GHDX, evaluating the profitability, health, valuation and growth aspects
- GENOMIC HEALTH INC (GHDX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENOMIC HEALTH INC (GHDX) Sales and EPS estimates to see what analysts future expectations are.
- GENOMIC HEALTH INC (GHDX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENOMIC HEALTH INC (GHDX) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENOMIC HEALTH INC (GHDX) Stock Chart to make your own analysis
- GENOMIC HEALTH INC (GHDX) Latest news and press-releases to stay up to date.
Does GENOMIC HEALTH INC (GHDX) stock pay dividends?
GHDX does not pay a dividend.
What is the Price/Earnings (PE) ratio of GENOMIC HEALTH INC (GHDX)?
The PE ratio for GENOMIC HEALTH INC (GHDX) is 44.36. This is based on the reported non-GAAP earnings per share of 1.43 and the current share price of 63.44 null. Check the full fundamental report for a full analysis of the valuation metrics for GHDX.
GHDX Technical Analysis
GHDX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GHDX. GHDX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
GHDX Financial Highlights
Over the last trailing twelve months GHDX reported a non-GAAP Earnings per Share(EPS) of 1.4300000000000002. The EPS increased by 186% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.81% | ||
| ROA | 12.29% | ||
| ROE | 16.2% | ||
| Debt/Equity | 0.15 |
GHDX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to GHDX. The Buy consensus is the average rating of analysts ratings from 8 analysts.